A month after Sutro closed an $85.4m series E round, the cancer drug developer, based on research at Stanford, has filed for a $75m initial public offering.

KTH foot scanner technology spinout Volumental has secured cash from Forward VC, Walerud Ventures and Moor Capital after previously closing a seed round in 2014.

Epigenomics services provider Epinomics, co-founded by Stanford University faculty and alumni, has been bought by 10x Genomics in a transaction which enables StartX to exit.

Vertex Pharmaceuticals has led a series B round for Genomics, a spinout from University of Oxford that also attracted Oxford Sciences Innovation and IP Group.

Food chain monitoring technology developer TeleSense has secured University of California-backed Congruent Ventures as an investor.

Princeton and Spelman College are among the investors in 645 Ventures' $40m fund, targeting segments such as online marketplaces and digitally-native consumer brands.

University of California-backed Congruent Ventures is among the investors in Bellwether Coffee, which is marketing an ethical coffee roasting system.

Nanovis, a spinal implant nanotechnology developer, has been backed by Elevate Purdue Foundry Fund, which joins existing investors including Apex One Equity Fund.

RXQ Compounding, backed by Ohio Innovation Fund, has added $3.6m in series A funding from Advantage Capital to its coffers.